Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells-Reference-Cited by-同舟云学术

Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

Published:2006-06 Issue:6 Volume:5 Page:657-664
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Liu Phillip C.C.,Liu Xiangdong,Li Yanlong,Covington Maryanne,Wynn Richard,Huber Reid,Hillman Milton,Yang Gengjie,Ellis Dawn,Marando Cindy,Katiyar Kamna,Bradley Jodi,Abremski Kenneth,Stow Mark,Rupar Mark,Zhuo Jincong,Li Yun-Long,Lin Qiyan,Burns David,Xu Meizhong,Zhang Colin,Qian Ding-Quan,He Chunhong,Sharief Vaqar,Weng Lingkai,Agrios Costas,Shi Eric,Metcalf Brian,Newton Robert,Friedman Steven,Yao Wenqing,Scherle Peggy A.,Hollis Gregory,Burn Timothy C.

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.5.6.2708

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer;Neoplasia;2024-11

2. A Non-Canonical p75HER2 Signaling Pathway Underlying Trastuzumab Action and Resistance in Breast Cancer;Cells;2024-08-29

3. Haramine-Mediated Anticancer Effects in Breast Cancer Cells: Targeting TAZ as a Therapeutic Strategy;International Journal of Advanced Research in Science, Communication and Technology;2024-08-02

4. New insight into the role of the ADAM protease family in breast carcinoma progression;Heliyon;2024-02

5. Overexpression of ADAM10 correlates with poor prognosis and immune infiltrates in breast cance;2024-01-25